
Therapeutic efficacy of HBsAg-anti-HBs-recombinant DNA harboring hepatitis B virus (HBV) S gene complex was compared with three other therapeutic vaccine candidates (recombinant HBsAg, HBsAg complexed to anti-HBs antibodies and naked plasmid DNA encoding the HBV S gene). After four injections at 3-week intervals, the most pronounced decrease of serum HBsAg, the highest titer of anti-HBs response, the highest level of interferon-gamma produced by splenocytes and potent cytotoxicity T cell response were observed in the HBsAg-anti HBs-sDNA immunized group. Reduced expression of HBsAg in hepatocytes was also shown. The therapeutic mechanism of HBsAg-anti-HBs-DNA was speculated as modulation of HBsAg presentation via both endogenous and exogenous pathways.
Cytokines - Biosynthesis, Hepatitis B virus, Dna, Recombinant - Immunology, T-Lymphocytes, Cytotoxic - Immunology, DNA, Recombinant, Mice, Transgenic, Antigen-Antibody Complex, Inbred C57bl, Hepatitis B Surface Antigens - Blood - Immunology, Transgenic, Mice, Recombinant - Immunology, Animals, Hepatitis B Vaccines, Hepatitis B - Therapy, Hepatitis B Antibodies, T-Lymphocytes, Cytotoxic - Immunology, Hepatitis B Surface Antigens, Immune tolerance, Dna, Therapeutic vaccine, Hepatitis B, Mice, Inbred C57bl, Antigen-Antibody Complex - Immunology, Mice, Inbred C57BL, Hepatitis B Vaccines - Therapeutic Use, Hepatitis B Antibodies - Immunology, Liver - Pathology - Virology, Liver, Cytokines, T-Lymphocytes, Cytotoxic
Cytokines - Biosynthesis, Hepatitis B virus, Dna, Recombinant - Immunology, T-Lymphocytes, Cytotoxic - Immunology, DNA, Recombinant, Mice, Transgenic, Antigen-Antibody Complex, Inbred C57bl, Hepatitis B Surface Antigens - Blood - Immunology, Transgenic, Mice, Recombinant - Immunology, Animals, Hepatitis B Vaccines, Hepatitis B - Therapy, Hepatitis B Antibodies, T-Lymphocytes, Cytotoxic - Immunology, Hepatitis B Surface Antigens, Immune tolerance, Dna, Therapeutic vaccine, Hepatitis B, Mice, Inbred C57bl, Antigen-Antibody Complex - Immunology, Mice, Inbred C57BL, Hepatitis B Vaccines - Therapeutic Use, Hepatitis B Antibodies - Immunology, Liver - Pathology - Virology, Liver, Cytokines, T-Lymphocytes, Cytotoxic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 54 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
